Startseite Medizin Heat stable carbetocin vs. oxytocin for the prevention of post-partum hemorrhage in emergency caesarean delivery: a randomized controlled trial
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Heat stable carbetocin vs. oxytocin for the prevention of post-partum hemorrhage in emergency caesarean delivery: a randomized controlled trial

  • Shaymaa Al Zubaidi und Taghreed Alhaidari ORCID logo EMAIL logo
Veröffentlicht/Copyright: 20. September 2021

Abstract

Objectives

To evaluate the uterotonic effect of carbetocin compared with oxytocin in emergency cesarean delivery in Iraq.

Methods

A double-blinded randomized noninferiority single center trial. Three-hundred patients were systematically randomized to intravenous bolus injection of 10 IU oxytocin or 100 mcg carbetocin after delivery in a ratio of 2:1. The primary outcome was additional uterotonic use when inadequate uterine tone occur in the first 24 h after delivery. Secondary outcomes include the need for blood transfusion, blood pressure and pulse rate changes within an hour of drugs administration. Noninferiority margins for the relative risks outcomes was 4%.

Results

Addition uterotonics use was significantly lower in carbetocin group with a risk ratio of 0.36. Carbetocin was superior to oxytocin in reducing the need for additional uterotonic drugs by 12% and non-inferior to oxytocin for blood transfusion 3.5%. Noninferiority was not shown for the outcome of sever blood loss. Miner changes in blood pressure and pulse rate were observed in carbetocin group compared to oxytocin but clinically were not significant.

Conclusions

Heat stable carbetocin is effective in reducing additional uterotonics use compared to oxytocin without clinically significant change in blood pressure or pulse rate, therefore, can be a potential alternative in Iraq.


Corresponding author: Dr. Taghreed AIhaidari, A/Prof., Consultant OBGYN, Department of Obstetrics and Gynaecology, Al Kindy College of Medicine, University of Baghdad, Elwiyah Maternity Teaching Hospital, Iraqi Board for Medical Specializations, Baghdad, Iraq, Phone: + 964 7906216647, E-mail:

Acknowledgments

The authors would like to thank Al Resafa Health Directorate for supplying the used drug for this research work. They are also thankful to Al Elwiya Maternity Teaching Hospital medical staff, namely the manager, Dr. Ulfat Alnakkash for their support and Al-Kindy Medical School at the University of Baghdad for supporting registration of this trial. Special gratitude to Dr. Ahmed S Alnuaimi for his valuable expert scientific analysis for the data.

  1. Research funding: None declared.

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Informed consent was obtained from all individuals included in this study.

  5. Ethical approval: The protocol was approved by the Scientific Affairs Unit and Medical Ethics Committee at Al Kindy College of Medicine and the hospital administrative boards’ official order (No 167 in 25/12/2017).

References

1. World Health Organization- Iraq Office. Maternal deaths drop by 29% from 1990 to 2010 in Iraq; 2013. Available from: https://www.uniraq.org/index.php?option=com_k2&view=item&id=141:maternal-deaths-drop-by-29-from-1990-to-2010-in-iraq&Itemid=605&lang=en.Suche in Google Scholar

2. Rani, PR, Begum, J. Recent advances in the management of major postpartum haemorrhage-a review. J Clin Diagn Res 2017;11:QE01. https://doi.org/10.7860/JCDR/2017/22659.9463.Suche in Google Scholar

3. Al-Kayat, E. Maternal mortality in cities of Iraq for three years. Int J Curr Microbiol App Sci 2016;5:590–611.10.20546/ijcmas.2016.501.061Suche in Google Scholar

4. Adnan, N, Boland, F, Murphy, D. Intramuscular oxytocin versus intravenous oxytocin to prevent postpartum haemorrhage at vaginal delivery (LabOR trial): study protocol for a randomised controlled trial. Trials 2017;18:1–10. https://doi.org/10.1186/s13063-017-2269-9.Suche in Google Scholar

5. World Health Organization. WHO recommendations for the prevention and treatment of postpartum haemorrhage. Italy: World Health Organization; 2012.Suche in Google Scholar

6. Torloni, MR, Gomes Freitas, C, Kartoglu, U, Metin Gülmezoglu, A, Widmer, M. Quality of oxytocin available in low‐and middle‐income countries: a systematic review of the literature. BJOG 2016;123:2076–86. https://doi.org/10.1111/1471-0528.13998.Suche in Google Scholar

7. Hogerzeil, HV, Walker, GJA, de Goeje, MJ, WHO Action Programme on Essential Drugs, World Health Organization. Safe Motherhood Research Programme. Stability of injectable oxytocics in tropical climates: results of field surveys and simulation studies on ergometrine, methylergometrine and oxytocin / H. V. Hogerzeil, G. J. A. Walker, M. J. de Goeje. Geneva: World Health Organization; 1993.Suche in Google Scholar

8. Berard, V, Fiala, C, Cameron, S, Bombas, T, Parachini, M, Gemzell-Danielsson, K. Instability of misoprostol tablets stored outside the blister: a potential serious concern for clinical outcome in medical abortion. PloS One 2014;9:e112401. https://doi.org/10.1371/journal.pone.0112401.Suche in Google Scholar

9. Hunter, DJ, Schulz, P, Wassenaar, W. Effect of carbetocin, a long‐acting oxytocin analog on the postpartum uterus. Clin Pharmacol Therapeut 1992;52:60–7. https://doi.org/10.1038/clpt.1992.103.Suche in Google Scholar

10. Borruto, F, Treisser, A, Comparetto, C. Utilization of carbetocin for prevention of postpartum hemorrhage after cesarean section: a randomized clinical trial. Obstet Gynecol Surv 2010;65:148–9. https://doi.org/10.1097/01.ogx.0000369666.65789.3a.Suche in Google Scholar

11. Dansereau, J, Joshi, AK, Helewa, ME, Doran, TA, Lange, IR, Luther, ER, et al.. Double-blind comparison of carbetocin versus oxytocin in prevention of uterine atony after cesarean section. Am J Obstet Gynecol 1999;180:670–6. https://doi.org/10.1016/s0002-9378(99)70271-1.Suche in Google Scholar

12. Malm, M, Madsen, I, Kjellström, J. Development and stability of a heat‐stable formulation of carbetocin for the prevention of postpartum haemorrhage for use in low and middle‐income countries. J Pept Sci 2018;24:e3082. https://doi.org/10.1002/psc.3082.Suche in Google Scholar PubMed PubMed Central

13. Mavrides, E, Allard, S, Chandraharan, E, Collins, P, Green, L, Hunt, BJ, et al.. Prevention and management of postpartum haemorrhage. BJOG 2016;124:e106–49. https://doi.org/10.1111/1471-0528.14178.Suche in Google Scholar PubMed

14. Iraqi Ministry of Health. Annual statistical report 2018. Baghdad, Iraq: Minisry of Health; 2019.Suche in Google Scholar

15. Razali, N, Latar, ILM, Chan, YK, Omar, SZ, Tan, PC. Carbetocin compared to oxytocin in emergency cesarean section: a randomized trial. Eur J Obstet Gynecol Reprod Biol 2016;198:35–9. https://doi.org/10.1016/j.ejogrb.2015.12.017.Suche in Google Scholar

16. Voon, HY, Suharjono, HN, Shafie, AA, Bujang, MA. Carbetocin versus oxytocin for the prevention of postpartum hemorrhage: a meta-analysis of randomized controlled trials in cesarean deliveries. Taiwan J Obstet Gynecol 2018;57:332–9. https://doi.org/10.1016/j.tjog.2018.04.002.Suche in Google Scholar

17. Heesen, M, Carvalho, B, Carvalho, JCA, Duvekot, JJ, Dyer, RA, Lucas, DN, et al.. International consensus statement on the use of uterotonic agents during caesarean section. Anaesthesia 2019;74:1305–19. https://doi.org/10.1111/anae.14757.Suche in Google Scholar

18. Widmer, M, Piaggio, G, Nguyen, TMH, Osoti, A, Owa, OO, Misra, S, et al.. WHO CHAMPION Trial Group. Heat-stable carbetocin versus oxytocin to prevent hemorrhage after vaginal birth. N Engl J Med 2018;379:743–52. https://doi.org/10.1056/nejmoa1805489.Suche in Google Scholar

19. Jin, B, Du, Y, Zhang, F, Zhang, K, Wang, L, Cui, L. Carbetocin for the prevention of postpartum hemorrhage: a systematic review and meta-analysis of randomized controlled trials. J Matern Fetal Neonatal Med 2016;29:400–7. https://doi.org/10.3109/14767058.2014.1002394.Suche in Google Scholar

20. Onwochei, D, Van Ross, J, Singh, P, Salter, A, Monks, D. Carbetocin reduces the need for additional uterotonics in elective caesarean delivery: a systematic review, meta-analysis and trial sequential analysis of randomised controlled trials. Int J Obstet Anesth 2019;40:14–23. https://doi.org/10.1016/j.ijoa.2019.06.007.Suche in Google Scholar

21. Su, LL, Chong, YS, Samuel, M. Carbetocin for preventing postpartum haemorrhage. Cochrane Database Syst Rev 2012;18(4):CD005457. https://doi.org/10.1002/14651858.cd005457.pub4.Suche in Google Scholar

22. Reyes, OA, Gonzalez, GM. Carbetocin versus oxytocin for prevention of postpartum hemorrhage in patients with severe preeclampsia: a double-blind randomized controlled trial. J Obstet Gynaecol Can 2011;33:1099–104. https://doi.org/10.1016/s1701-2163(16)35077-0.Suche in Google Scholar

23. Rosseland, LA, Hauge, TH, Grindheim, G, Stubhaug, A, Langesæter, E. Changes in blood pressure and cardiac output during cesarean delivery: the effects of oxytocin and carbetocin compared with placebo. Anesthesiology 2013;119:541–51. https://doi.org/10.1097/aln.0b013e31829416dd.Suche in Google Scholar

24. Ibrahim, ZM, Sayed Ahmed, WA, Abd El-Hamid, EM, Taha, OT, Elbahie, AM. Carbetocin versus oxytocin for prevention of postpartum hemorrhage in hypertensive women undergoing elective cesarean section. Hypertens Pregnancy 2020;39:319–25. https://doi.org/10.1080/10641955.2020.1768268.Suche in Google Scholar PubMed

25. Briones, JR, Talungchit, P, Thavorncharoensap, M. Economic evaluation of carbetocin as prophylaxis for postpartum hemorrhage in the Philippines. BMC Health Serv Res 2020;20:1–12. https://doi.org/10.1186/s12913-020-05834-x.Suche in Google Scholar PubMed PubMed Central

Received: 2021-05-07
Accepted: 2021-08-16
Published Online: 2021-09-20
Published in Print: 2022-02-23

© 2021 Walter de Gruyter GmbH, Berlin/Boston

Artikel in diesem Heft

  1. Frontmatter
  2. Corner of Academy
  3. External cephalic version in the outpatient clinic
  4. Original Articles – Obstetrics
  5. How COVID-19 pandemic is changing the practice of prenatal screening and diagnosis?
  6. Analysis of prevalence and sociodemographic conditions among women in labor with and without COVID-19 in public hospitals in Chile
  7. Influence of Covid-19 infection on fetal thymus size after recovery
  8. Second trimester fetal thymus size in association to preterm birth
  9. Heat stable carbetocin vs. oxytocin for the prevention of post-partum hemorrhage in emergency caesarean delivery: a randomized controlled trial
  10. Enhanced S100B expression in T and B lymphocytes in spontaneous preterm birth and preeclampsia
  11. The impact of parity and maternal obesity on the fetal outcomes of a non-selected Lower Saxony population
  12. Importance of frame rate for the measurement of strain and synchrony in fetuses using speckle tracking echocardiography
  13. Kidney graft function before pregnancy as a predictor of graft, maternal and fetal outcomes in pregnant renal transplant recipients
  14. Sociodemographic factors affecting perceived stress during pregnancy and the association with immune-mediator concentrations
  15. Original Articles – Neonates
  16. Smoking influence on early and late fetal growth
  17. Maternal oxytocin administration modulates gene expression in the brains of perinatal mice
  18. Original Articles – Fetus
  19. Human epididymis protein 4 and fetal lung maturity
  20. Commentary
  21. Plato unmasks hidden limits of tele-education
  22. Letter to the Editors
  23. COVID-19 delta variant and anxiety and fear in pregnant women
  24. Reply to: COVID-19 Delta variant and anxiety and fear in pregnant women
  25. COVID-19 infected pregnant women and cardiotocographic features
  26. Letter Reply
  27. Response to the concern that the baseline change in CTG traces does not reflect the impact of maternal COVID-19
Heruntergeladen am 31.12.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jpm-2021-0206/html
Button zum nach oben scrollen